# A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma

> **NCT04316091** · PHASE1 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 60 (estimated)

## Conditions studied

- Osteosarcoma

## Interventions

- **DRUG:** neoadjuvant chemotherapy+SPIONs/SMF
- **DRUG:** neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT04316091
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04316091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04316091, "A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04316091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*